Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ratner

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Nature Biotechnology|June 10, 2015
Heart failure gene therapy disappoints but experts keep the faithMark Ratner
Nature Biotechnology|October 8, 2005
New IGF drug stirs competition in growth factor segmentMark Ratner
Nature Reviews. Drug Discovery|May 3, 2005
Industry shrugs off NIH consulting banMark Ratner
Nature Biotechnology|May 7, 2005
Earlier stage biotechs attract partnersMark Ratner
Nature Medicine|March 9, 2011
Fearful of Avastin's fate, Genentech asks for unusual hearingMark Ratner
Nature Biotechnology|April 12, 2011
Genzyme-Sanofi buy out is second largest biotech deal everMark Ratner
Nature Biotechnology|October 15, 2010
Genzyme resumes shipping as Sanofi-aventis hoversMark Ratner
Nature Medicine|June 8, 2012
Straight talk with...Joseph SchwartzMark Ratner
Nature Biotechnology|August 7, 2018
FDA backs clinician-free AI imaging diagnostic toolsMark Ratner
Nature Biotechnology|October 8, 2004
Genentech discloses safety concerns over AvastinMark Ratner
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Nature Biotechnology|June 10, 2015
Heart failure gene therapy disappoints but experts keep the faithMark Ratner
Nature Biotechnology|October 8, 2005
New IGF drug stirs competition in growth factor segmentMark Ratner
Nature Reviews. Drug Discovery|May 3, 2005
Industry shrugs off NIH consulting banMark Ratner
Nature Biotechnology|May 7, 2005
Earlier stage biotechs attract partnersMark Ratner
Nature Medicine|March 9, 2011
Fearful of Avastin's fate, Genentech asks for unusual hearingMark Ratner
Nature Biotechnology|April 12, 2011
Genzyme-Sanofi buy out is second largest biotech deal everMark Ratner
Nature Biotechnology|October 15, 2010
Genzyme resumes shipping as Sanofi-aventis hoversMark Ratner
Nature Medicine|June 8, 2012
Straight talk with...Joseph SchwartzMark Ratner
Nature Biotechnology|August 7, 2018
FDA backs clinician-free AI imaging diagnostic toolsMark Ratner
Nature Biotechnology|October 8, 2004
Genentech discloses safety concerns over AvastinMark Ratner
Pageof 11